Search

everythinglearnresearchcommunity

for

Search:↓

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

New treatment with Wnt proteins and growth factors safely increases hair thickness.

Topical 5% minoxidil is safe and effective for treating hair loss in Korean men.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

The new 5% minoxidil foam is as effective and safe as Rogaine® for treating hair loss in Chinese men.

The oral contraceptive with ethinyl estradiol and chlormadinone acetate is effective in treating moderate acne.

A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.

Using 5% minoxidil foam twice daily can help regrow hair, especially in younger men aged 20-30.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

c-Kit is important for heart regeneration and cancer development.

PLD is an effective and safer alternative for treating breast cancer.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Promising cancer treatments were found, but the manufacturer closed.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Finasteride improves hair growth and satisfaction in men with male pattern baldness but may cause sexual side effects.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Targeting macrophages may improve wound healing.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.